Forward-Looking Analysis
Wall Street analysts project SpaceXSPCX-- (SPCX) to report revenue of $6.88 billion for the second quarter of 2026, with a consensus range spanning from $5.30 billion to $8.44 billion. On the earnings front, the company is expected to post an EPS of -$0.23, reflecting a broad analyst estimate range between -$0.41 and $0.09. Despite these losses, the broader analyst sentiment remains cautiously optimistic, characterized by a "Moderate Buy" consensus based on 38 recent ratings. The average 12-month price target stands at approximately $233.18, with significant variance among institutions; targets range from a low of $75.00, initiated by Phillip Securities with a Sell rating, to a high of $800.00. Prominent firms such as Morgan Stanley ($300), Deutsche Bank ($255), and Needham ($250) maintain Buy or Outperform ratings, citing Starship progress and AI infrastructure potential. However, skepticism exists, with HSBC initiating coverage at Hold ($115) and Phillip Securities at Sell ($75). Key concerns driving the negative estimates include SpaceX's aggressive capital expenditure plans, projected to surge from $48.7 billion in FY2026 to $118.4 billion in FY2028, alongside debt growth exceeding fivefold to over $218 billion. Investors are closely watching whether these massive AI and space infrastructure investments will yield healthy returns amidst the upcoming lockup expiration.
Quick Backtesting Tool
Historical Performance Review
SpaceX’s 2026Q1 results revealed significant financial strain, reporting revenue of $4.69 billion against a gross profit of $2.31 billion. However, the bottom line suffered heavily, with net income plunging to -$4.28 billion and earnings per share settling at -$1.27. This substantial deficit highlights the company's intense burn rate as it scales operations, contrasting sharply with the modest losses expected in the subsequent quarter.
Additional News
SpaceX stock experienced extreme volatility ahead of the earnings release, closing at $108.37 after shedding approximately 30% from its $150 IPO debut and 50% from its all-time high of $225.64. A major overhang looms with a lockup expiration on August 6, potentially freeing 20% of shares for sale, which may suppress stock prices through increased supply. Concurrently, reports indicate CEO Elon Musk is pursuing a merger with Tesla (TSLA), raising regulatory and geopolitical concerns regarding Beijing’s scrutiny of Tesla’s Chinese factories and data from 2 million users. Additionally, the House Energy Committee has demanded a tour of SpaceX’s AI data centers in Memphis, signaling increased governmental oversight of its expanding AI infrastructure.
Summary & Outlook
SpaceX’s financial health remains precarious, evidenced by a massive $4.28 billion net loss in Q1 2026 despite $4.69 billion in revenue. While the company generates strong top-line growth, its profitability is severely hampered by aggressive capital expenditures projected to exceed $118 billion by 2028 and rapid debt accumulation. Growth catalysts include Starship development and AI infrastructure expansion, but these are offset by substantial risks: the impending lockup expiration threatens significant sell-side pressure, and potential regulatory hurdles regarding a Tesla merger create geopolitical uncertainty. Given the widening gap between investment scale and current returns, the outlook is neutral-to-bearish in the near term, as the market awaits evidence that capital-intensive projects will eventually stabilize EPS and justify the current valuation amidst heavy dilution fears.
